Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Retired doctors and more syringes: Biden lays out plan to get America vaccinated

Published 01/15/2021, 03:29 PM
Updated 01/15/2021, 09:22 PM
© Reuters. FILE PHOTO: U.S. President-elect Joe Biden delivers remarks on the U.S. response to the coronavirus disease (COVID-19) outbreak, at his transition headquarters in Wilmington

© Reuters. FILE PHOTO: U.S. President-elect Joe Biden delivers remarks on the U.S. response to the coronavirus disease (COVID-19) outbreak, at his transition headquarters in Wilmington

By Trevor Hunnicutt

WILMINGTON, Del. (Reuters) - U.S. President-elect Joe Biden on Friday said he would order increased production of syringes and other supplies to ramp up vaccinations against COVID-19 and improve upon the Trump administration rollout that he called a "dismal failure."

Under Biden's plan, federal disaster-relief workers would set up thousands of vaccination centers, where retired doctors would administer shots to teachers, grocery store workers, people over 65 years old and other groups who do not currently qualify.

The Democrat would invoke the Defense Production Act to increase production of equipment needed to distribute the vaccines, such as glass vials, needles and syringes, according to a document released by his transition team. He would also use the law to support vaccine refrigeration and storage.

Biden said his team has identified companies that are ready to be activated under the law, which enables the president to order businesses to produce items necessary for national defense.

States that use their National Guard in the effort would be reimbursed by the federal government, the transition team said.

The coronavirus has killed more than 390,000 people in the United States, and a top Biden adviser said on Friday the death tally could reach 500,000 by February.

Biden has promised to do better than President Donald Trump to curb the virus and get 100 million vaccine shots into the arms of Americans during his first 100 days in office.

"This is a time to set big goals and pursue them with courage and conviction because the health of the nation is literally at stake," said Biden, who takes office on Wednesday.

EXPANDING VACCINATION SITES

Speaking near his home in Wilmington, Delaware, Biden called for increasing vaccine distribution in lower-income neighborhoods not currently well served by hospitals and pharmacies. Biden also plans a marketing campaign to encourage those skeptical of the vaccine to get inoculated.

His transition team said he will reorganize the vaccine distribution team currently called "Operation Warp Speed" and has asked former Food and Drug Administration chief David Kessler to work with manufacturers to boost vaccine availability.

Biden said his administration will release the vast majority of doses when they become available, rather than holding back a large portion to ensure that recipients can get a second dose, which had been the Trump administration's approach for much of the rollout. States will get regular updates to know how many doses are coming to ensure they can distribute them efficiently.

He said he will order the Federal Emergency Management Agency to set up 100 vaccine centers within a month, which he said would ultimately serve millions of people. Neighborhood pharmacies would also be enlisted as vaccination sites, he said.

Even with these changes, Biden said it will take time for the United States to beat back the virus. "The honest truth is this: things will get worse before they get better," he said.

Biden unveiled a $1.9 trillion stimulus plan on Thursday that includes $20 billion for vaccine distribution as well as $50 billion for coronavirus testing, which experts and officials said should help speed the process up.

The stimulus proposal faces an uphill battle in Congress, however. When Biden takes office, Democrats will control both the Senate and the House of Representatives but by narrow margins. Some Republicans have balked at its cost, while liberals have pushed for more spending on direct payments to individuals.

The Trump administration had aimed to give vaccine doses to 20 million Americans by the end of 2020. But only 12.3 million coronavirus shots had been administered as of Friday morning out of more than 31 million doses distributed to states, according to data from the U.S. Centers for Disease Control and Prevention.

Federal officials have largely left states to manage distribution, resulting in big differences in vaccination rates. The Trump administration has said it expects 1 million shots to be delivered per day by the end of next week.

© Reuters. U.S. President-elect Joe Biden outlines coronavirus vaccine administration plan during news conference at transition headquarters in Wilmington, Delaware

A Trump administration official, speaking on condition of anonymity, said the United States is on track to have 300 million doses available by the end of Biden's first 100 days in office.

Latest comments

you know the reason those doctors retired is because of oamacare
we need the states and local governments to get their heads out of the sand and deliver the vaccines. they have had plenty of time to have figured this out. so disappointing.
An even better plan. https://investors.vaxart.com/static-files/76ded565-e448-4d98-910c-f1ae3629789c
weed. infra. green... portfolio updated.. :)
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.